Osteoporosis, Osteopenia Completed Phase 2 / 3 Trials for Denosumab (DB06643)

Back to Osteoporosis, Osteopenia

Also known as: Osteoporosis or Osteopenia / Osteopenia, Osteoporosis / Osteopenia/Osteoporosis

IndicationStatusPhase
DBCOND0034537 (Osteoporosis, Osteopenia)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04169698Alendronate Versus Denosumab in Kidney Transplant PatientsTreatment